HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a cell-based high throughput luciferase enzyme fragment complementation assay to identify nuclear-factor-e2-related transcription factor 2 activators.

Abstract
Nuclear-factor-E2-related transcription factor 2 (Nrf2) regulates a large panel of Phase II genes and plays an important role in cell survival. Nrf2 activation has been shown as preventing cigarette smoke-induced alveolar enlargement in mice. Therefore, activation of the Nrf2 protein by small-molecule activators represents an attractive therapeutic strategy that is used for chronic obstructive pulmonary disease. In this article, we describe a cell-based luciferase enzyme fragment complementation assay that identifies Nrf2 activators. This assay is based on the interaction of Nrf2 with its nuclear partner MafK or runt-related transcription factor 2 (RunX2) and is dependent on the reconstitution of a "split" luciferase. Firefly luciferase is split into two fragments, which are genetically fused to Nrf2 and MafK or RunX2, respectively. BacMam technology was used to deliver the fusion constructs into cells for expression of the tagged proteins. When the BacMam-transduced cells were treated with Nrf2 activators, the Nrf2 protein was stabilized and translocated into the nucleus where it interacted with MafK or RunX2. The interaction of Nrf2 and MafK or RunX2 brought together the two luciferase fragments that form an active luciferase. The assay was developed in a 384-well format and was optimized by titrating the BacMam concentration, transduction time, cell density, and fetal bovine serum concentration. It was further validated with known Nrf2 activators. Our data show that this assay is robust, sensitive, and amenable to high throughput screening of a large compound collection for the identification of novel Nrf2 activators.
AuthorsWensheng Xie, Christina Pao, Taylor Graham, Ed Dul, Quinn Lu, Thomas D Sweitzer, Robert S Ames, Hu Li
JournalAssay and drug development technologies (Assay Drug Dev Technol) Vol. 10 Issue 6 Pg. 514-24 (Dec 2012) ISSN: 1557-8127 [Electronic] United States
PMID22574653 (Publication Type: Journal Article)
Chemical References
  • Core Binding Factor Alpha 1 Subunit
  • Culture Media
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • RUNX2 protein, human
  • Small Molecule Libraries
  • Luciferases
  • Dimethyl Sulfoxide
Topics
  • Algorithms
  • Automation
  • Cell Count
  • Cloning, Molecular
  • Core Binding Factor Alpha 1 Subunit (metabolism)
  • Culture Media
  • Cytomegalovirus (genetics)
  • Data Interpretation, Statistical
  • Dimethyl Sulfoxide (pharmacology)
  • Genetic Complementation Test (methods)
  • Genetic Vectors
  • HEK293 Cells
  • High-Throughput Screening Assays (methods)
  • Humans
  • Luciferases (metabolism)
  • NF-E2-Related Factor 2 (agonists, drug effects)
  • Real-Time Polymerase Chain Reaction
  • Small Molecule Libraries
  • Transduction, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: